{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:38:27Z","timestamp":1762954707805},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.ijantimicag.2007.06.026","type":"journal-article","created":{"date-parts":[[2007,9,12]],"date-time":"2007-09-12T11:21:58Z","timestamp":1189596118000},"page":"409-414","source":"Crossref","is-referenced-by-count":27,"title":["Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates"],"prefix":"10.1016","volume":"30","author":[{"given":"Petros","family":"Kopterides","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patra K.","family":"Koletsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Argyris","family":"Michalopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E.","family":"Falagas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2007.06.026_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.qco.0000171920.44809.f0","article-title":"Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting","volume":"18","author":"Navon-Venezia","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1128\/AAC.47.5.1681-1688.2003","article-title":"Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001","volume":"47","author":"Karlowsky","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/314040","article-title":"Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility","volume":"31","author":"Wisplinghoff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/501822","article-title":"An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients","volume":"22","author":"Fierobe","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/archinte.162.13.1515","article-title":"Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned","volume":"162","author":"Landman","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3201\/eid0801.000454","article-title":"Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital Taiwan","volume":"8","author":"Hsueh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant Gram-negative bacteria","volume":"33","author":"Evans","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib8","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib9","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/AAC.48.5.1586-1592.2004","article-title":"In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains","volume":"48","author":"Higgins","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF01690727","article-title":"Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii","volume":"14","author":"Mulin","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/515067","article-title":"Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case\u2013control study of adult burn patients","volume":"28","author":"Wisplinghoff","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/645859","article-title":"Nosocomial respiratory tract colonization and infection with aminoglycoside-resistant Acinetobacter baumannii: epidemiology and clinical features","volume":"9","author":"Peacock","year":"1988","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1067\/mic.2002.122648","article-title":"Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii","volume":"30","author":"Mahgoub","year":"2002","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib14","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1128\/JCM.38.11.4086-4095.2000","article-title":"Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii","volume":"38","author":"Corbella","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1469-0691.2005.01184.x","article-title":"Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection","volume":"11","author":"del Mar Tomas","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1469-0691.2005.01256.x","article-title":"Spanish Group for Nosocomial Infection (GEIH) for the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study","volume":"11","author":"Cisneros","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/AAC.48.1.224-228.2004","article-title":"Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case\u2013control study","volume":"48","author":"Lee","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0195-6701(03)00046-X","article-title":"Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin\u2013sulbactam treatment","volume":"54","author":"Smolyakov","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.CCM.0000152230.53473.A1","article-title":"First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit","volume":"33","author":"Nseir","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/313902","article-title":"Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage","volume":"31","author":"Manikal","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3201\/eid1101.040001","article-title":"Multidrug-resistant Acinetobacter baumannii","volume":"11","author":"Abbo","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib22","series-title":"Hospital epidemiology and infection control","first-page":"1","article-title":"Surveillance of nosocomial infections. Appendix A: CDC definitions of nosocomial infections","author":"Gaynes","year":"1996"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib23","series-title":"Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib24","series-title":"Performance standard for antimicrobial disk susceptibility tests","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib25","series-title":"Performance standards for antimicrobial disc susceptibility tests","author":"National Committee for Clinical Laboratory Standards","year":"1981"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/322584","article-title":"Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study","volume":"33","author":"G\u00e1rcia-Garmendia","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-129-3-199808010-00003","article-title":"Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology","volume":"129","author":"Villers","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib28","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/381550","article-title":"Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity","volume":"38","author":"Paramythiotou","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00134-005-2598-0","article-title":"Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings","volume":"31","author":"Garnacho-Montero","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib30","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00134-006-0239-x","article-title":"Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: a case\u2013control study","volume":"32","author":"Katragkou","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2007.06.026_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0305-4179(02)00012-8","article-title":"Multi-resistant Acinetobacter baumannii on a burns unit\u2014clinical risk factors and prognosis","volume":"28","author":"Wong","year":"2002","journal-title":"Burns"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907003135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907003135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T13:18:17Z","timestamp":1587907097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907003135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0924857907003135"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.06.026","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}